AWM Investment Company’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
VCM
VPM
N
AWM Investment Company's ADMA Position: Q1 2026 in Review
AWM Investment Company sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 2,200,000 shares — an estimated $40.1M sold.
AWM Investment Company first reported a position in ADMA in Q4 2021 and held it in 17 quarters. The position peaked at $89M in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.
- AWM Investment Company reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
- AWM Investment Company sold 2,200,000 ADMA Biologics shares in Q1 2026, an estimated $40.1M.
- AWM Investment Company first reported a position in ADMA Biologics in Q4 2021 and held it in 17 quarters.
- AWM Investment Company's ADMA Biologics position peaked at $89M in Q3 2024.
- 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.
Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.